Related references
Note: Only part of the references are listed.Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome
Giulio Disanto et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
The prognostic value of CSF neurofilaments in multiple sclerosis at 15-year follow-up
Axel Petzold
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Neurofilament light chain A prognostic biomarker in amyotrophic lateral sclerosis
Ching-Hua Lu et al.
NEUROLOGY (2015)
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
Jens Kuhle et al.
NEUROLOGY (2015)
An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease
Daniel Schmitter et al.
NEUROIMAGE-CLINICAL (2015)
CSF neurofilament light chain but not FLT3 ligand discriminates parkinsonian disorders
Megan K. Herbert et al.
FRONTIERS IN NEUROLOGY (2015)
Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis
L. M. Villar et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Multicontrast Connectometry: A New Tool to Assess Cerebellum Alterations in Early Relapsing-Remitting Multiple Sclerosis
David Romascano et al.
HUMAN BRAIN MAPPING (2015)
Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome
Jens Kuhle et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Assessing tissue damage in multiple sclerosis: a biomarker approach
J. Burman et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Cerebrospinal Fluid Neurofilament Concentration Reflects Disease Severity in Frontotemporal Degeneration
Carole S. Scherling et al.
ANNALS OF NEUROLOGY (2014)
Myelin and iron concentration in the human brain: A quantitative study of MRI contrast
Carsten Stueber et al.
NEUROIMAGE (2014)
Natalizumab in progressive MS Results of an open-label, phase 2A, proof-of-concept trial
Jeppe Romme Christensen et al.
NEUROLOGY (2014)
Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis
Guillaume Bonnier et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis
Jeppe Romme Christensen et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
M. Khalil et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
A comparative study of CSF neurofilament light and heavy chain protein in MS
Jens Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Micro-Structural Brain Alterations in Aviremic HIV plus Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field
Cristina Granziera et al.
PLOS ONE (2013)
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
Johanna Gaiottino et al.
PLOS ONE (2013)
Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis
Signe Modvig et al.
PLOS ONE (2013)
Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Axonal damage in the making: Neurofilament phosphorylation, proton mobility and magnetisation transfer in multiple sclerosis normal appearing white matter
A. Petzold et al.
EXPERIMENTAL NEUROLOGY (2011)
Neurofilament light as a prognostic marker in multiple sclerosis
Jonatan Salzer et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis
C. E. Teunissen et al.
NEUROLOGY (2009)
Neurochemical aftermath of amateur boxing
Henrik Zetterberg et al.
ARCHIVES OF NEUROLOGY (2006)
Fit-for-purpose method development and validation for successful biomarker measurement
JW Lee et al.
PHARMACEUTICAL RESEARCH (2006)
Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss
A Petzold
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS
C Malmeström et al.
NEUROLOGY (2003)
Medical progress: Multiple sclerosis.
JH Noseworthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)